Development of BIOCEV team - a key condition of Excellence

Provider

Ministry of Education, Youth and Sports

Programme

—

Call for proposals

—

Main participants

Ústav molekulární genetiky AV ČR, v. v. i.

Contest type

OP - EU Operational Programme

Contract ID

45206/13

Project name in Czech

Rozvoj týmu BIOCEV - klíčová podmínka excelence

Annotation in Czech

Projekt na základě atraktivního finančního ohodnocení a atraktivity samotného centra BIOCEV usiluje o získání mimořádně talentované osobnosti na pozici ředitele BIOCEV (Prof. MUDr. Pavel Martásek, DrSc.). Konkrétně se projekt zaměřuje na: 1/ Mentoring 6vybraných mentees, kteří se budou v rámci shadowingu účastnit pracovních a rozhodovacích procesů ředitele BIOCEV, dále absolvují jako doprovod několik služebních cest ředitele BIOCEV, budou vysláni do několika dříve benchmarkovaných center excelence a budou se účastnit tuzemských seminářů a workshopů vedených ředitelem BIOCEV (mentoring/shadowing). 2/ Šíření best practice v prostředí VŠ v rámci realizace specializovaných přednášek a workshopů na českých vysokých školách zaměřených na problematiku managementu vědy a konkurenceschopnosti center VaV, které povede ředitel BIOCEV.

R&D category

ZV - Basic research

CEP classification - main branch

EI - Biotechnology and bionics

CEP - secondary branch

—

CEP - another secondary branch

—

OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics

Provider evaluation

U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

Project results evaluation

BIOCEV director became candidate who met the professional and qualifying criteria defined by BIOCEV and approved by the MA OP VaVpI. The Director during monitoring periods implemented with mentees many consultations. To grasp BIOCEV "world", prof. Martásek implemented job rotations with members of BIOCEV implementation team. Six foreign journeys were carried out to selected centers of excellence.

Realization period - beginning

Jan 1, 2013

Realization period - end

Jun 30, 2015

Project status

U - Finished project

Latest support payment

Jul 3, 2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data delivery code

CEP16-MSM-EE-U/01:1

Data delivery date

Sep 27, 2017

Total approved costs

10,567 thou. CZK

Public financial support

10,567 thou. CZK

Other public sources

0 thou. CZK

Non public and foreign sources

0 thou. CZK